phoneCall Now for a Free Case Evaluation - 800-611-7080
Seedol.com > News > Depuy Hip Lawsuit

Depuy Hip Lawsuit News and Info

February 18, 2013 by
Depuy Hip Lawsuit

Depuy Hip Lawsuit

02/18/2013  In the midst of an ongoing Depuy Hip Implant Lawsuit due to defects, new issues arise with Depuy Hip Implants as well as other metal on metal hip implants. Johnson and Johnson already faces the prospect of a large number of trials from lawsuits filed after a previous Depuy Hip Implant recall due to defects. Now new Depuy Hip Lawsuits are expected as a result of new medical issues with a large number of hip implants devices.

Current Depuy Hip Class Action Lawsuit

Currently, there is a depuy hip lawsuit ongoing over defects in certain Depuy Hip products that lead to the need for a large number of depuy hip implant recipients to have to have their Depuy Hip Implant replaced. The current Depuy Hip Class Action Lawsuit or as it is more appropriately called, the Depuy Lawsuit Multidistrict Litigation is going in Federal Court. Weather Depuy Hip Lawsuits filed due the new issues with Depuy Hip Implants will be formed into a separate Depuy Class Action Lawsuit or be joined with the current action is yet to be known.

New Issues Evolve as Depuy Hip Lawsuit Settlements Considered

The new medical issues, which involve metal particles breaking lost from hip implants and entering the blood stream came to light Depuy Lawsuit Settlement Talks were underway from previous cases filed. Now the issue with Metallosis has been discovered and Johnson and Johnson faces the probability of a large number of new Depuy Hip Lawsuits in the coming years.

What is Metallosis?

Metalosis decribes  the build up of metal particles in the blood stream or soft tissues of the body. Metalosis can cause numerous serious medical conditions and can be extremely difficult to treat.  The current issue with metal on metal hip replacements involving metallosis occurs when a hip replacement patients implant sheds medical particles which enter tissues and the blood stream and cause a variety of health problems, some of which could be fatal.

For More Information Metallosis due to hip implants, or to inquire about filing a depuy hip lawsuit, feel free to contact us:

Best Legal Source

(800) 611-7080.

Filed Under: Depuy Hip Lawsuit Tagged With: , ,

FDA Initiative to Investigate Hip Replacement Dangers

April 19, 2012 by

(New York, NY, April 19, 2012) American Law Partners, which represents clients with claims stemming from the dangerous side effects of defective medical devices, is fully supportive of the efforts of the U.S. Food and Drug Administration (FDA) to study the dangers posed by metal-on-metal hip replacement implants.

According to a recent Reuters report, on June 27-28, the FDA will be consulting with an advisory panel of experts to re-evaluate metal-on-metal hip replacement implants. “Though the FDA metal hip implant investigation is nothing new,” Reuters reports, “it signals the agency may be ready to subject the devices to stricter scrutiny.”

After the August 2010 recall of 93,000 DePuy XL Acetabular metal-on-metal hip replacement devices, the FDA ordered manufacturers to collect more post-implant safety data. Since then, the FDA has been investigating the safety of metal hip implants and trying to decide if they should undergo more rigorous testing and premarket review. “Evidence suggests that such review may be necessary. A recent study from the National Joint Registry of England and Wales found that 6 percent of people with metal hip replacements needed additional surgery,” Reuters reports. “This is high when compared to the 1.7 to 2.4 percent rate found in individuals with ceramic or plastic hips.”

 

The American Law Parnters  lawyers have experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations.  Affected individuals can also stay apprised of the latest developments in the DePuy situation by visiting the DePuy  ASR Hip Replacement Lawsuit Information Center. The site is equipped with easy-to-use social media features which will enable users to spread the word about DePuy ASR hip replacement device failures.

 

Filed Under: Depuy Hip Lawsuit, Featured Tagged With: ,

A Hip Recall Discussion will take place at Mass Tort Seminar

September 20, 2011 by

A Hip Recall Discussion will take place at Mass Tort Seminar
(September 20, 2011) A Hip Recall discussion will be but one of the many topics presented at “Not Your Typical Plaintiff Lawyer’s Seminar” that will be taking place at the 10th anniversary celebration of Mass Torts Made Perfect and Torts Made Perfect. This highly anticipated event will take place at the Bellagio Hotel and Casino in Las Vegas, Nevada on October 12th-14th, 2011. The agenda put together for this seminar was designed to, “help plaintiff attorneys succeed in all aspects of their practices, from attracting clients to preparing for trials against formidable opponents”.

The Depuy Hip Recall is still a hot subject today, even after a year of its having been recalled. Many believe that there are still unanswered questions in reference to this Hip Replacement Recall and many patients are still suffering from the defective product. This Hip Implant Recall was brought about after the United States Food and Drug Administration issued a statement declaring that, “On August 24, 2010, there was a voluntary recall of the Depuy ASR total hip system because of new, unpublished data from the UK joint registry indicating the revision rates within 5 years were approximately 13 percent”.

Hip Recall law firms are still receiving phone calls on a daily basis from people who are suffering serious complications from their defective hip replacements and are seeking out legal advice for a possible Hip Implant Recall Lawsuit. One such call that led to a major Hip Replacement Recall lawsuit was that of a Michigan woman who filed a lawsuit against Depuy Orthopedics Inc. and its parent company Johnson & Johnson claiming that they purposely concealed the device’s harmful effects to consumers.

If you were affected by the Hip Recall or if you have had any type of hip replacement implant that has been causing unusual pain and discomfort, then it is important to contact a reputable hip recall attorney to find out about your legal rights in reference to a Hip Replacement Recall and to answer any other questions that you may have.

If you are interested in finding out more about the Mass Torts Made Perfect and Torts Made Perfect 10th anniversary seminar, then please visit their website at: www.masstortsmadeperfect.com to get all the details about registration, guest speakers and topic agendas such as the Depuy Hip Recall.

Filed Under: Breaking News, Depuy Hip Lawsuit, FDA Recall, Featured, General Legal, Law Firm Marketing, Mass Tort News, Medical Device Lawsuits

Hip Replacement Client Data Supports Conclusions of National Joint Registry for England and Wales

September 20, 2011 by

New York, September 20, 2011. American Law Patners, which represent clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, has considered the conclusions of the 8th Annual Report of the National Joint Registry for England and Wales in light of the firm’s own client records and found that the data do indeed correspond.

The National Joint Registry (NJR) of England and Wales was established in 2002. Its purpose, according to the group’s website, is “to define, improve and maintain the quality of care of individuals receiving hip, knee and ankle joint replacement surgery across the [National Health Service in the United Kingdom] and the independent healthcare sector.” The 8th Annual Report of the NJR is the “formal public report for the period 1st April 2010 to 31st March 2011,” according to the front matter of the report itself.

Among other conclusions contained in the report is the following, regarding revision—defined as an “operation performed to remove (and usually replace) one or more components of a total joint prosthesis for whatever reason”—and metal-on-metal joint replacement systems: “[T]he risk of revision for metal-on-metal and resurfacing prostheses was considerably higher than those for other bearing surfaces. Metal-on-metal was close to the revision rate for resurfacing (also metal-on-metal) up to six years after surgery but then appears to overtake the resurfacing revision rate. This is because of a sharp increase in the risk of revision at around six years for the metal-on-metal group.”

The American Law Partners notes that the largest part of those contacting the firm seeking representation stemming from the implantation of a replacement joint device received a metal-on-metal implant—either a DePuy ASR or Pinnacle, or another device. In August of 2010, DePuy—a subsidiary of Johnson & Johnson—announced a global recall of the ASR Hip Resurfacing System and the ASR XL Acetabular System. Each unit replaces a worn or weakened part of the hip. Many orthopedic doctors believe that the units were poorly designed; the implants can generate debris from wear, causing inflammation and tissue damage in recipients. Ninety three thousand persons worldwide had an ASR device implanted. More recently, problems with DePuy’s Pinnacle hip replacement system came to light. In May, federal actions against DePuy and J&J concerning the Pinnacle hip replacement system were consolidated for pretrial proceedings in multidistrict litigation. Claimants allege in these suits that the Pinnacle system was defectively designed and/or that DePuy failed to provide adequate warnings concerning the Pinnacle, and specifically with regard to the possibility that the Pinnacle, a metal-on-metal mechanism, is shedding metallic particles into recipients bloodstreams and tissues.

 

 

Filed Under: Depuy Hip Lawsuit, Featured Tagged With: , ,

FDA Approval of First Ceramic-on-Metal Total Hip Replacement System

June 16, 2011 by

American Law Partners, which represents clients with claims stemming from the failures of defective hip replacement devices manufactured and sold by DePuy Orthopaedics, a division of Johnson & Johnson, is wary but hopeful that the first ceramic-on-metal total hip replacement system approved by the U.S. Food and Drug Administration (FDA) will not be hindered by the problems that have plagued metal-on-metal implant systems such as DePuy’s Pinnacle system.

According to its June 14, 2011 press release, the FDA granted approval on June 13 to the first ceramic-on-metal total artificial hip system for use in patients suffering from osteoarthritis.

The FDA release explains, “Hip joints consist of bone in the shape of a ball at the top of the thigh bone (femur) that fits into a rounded socket in the pelvis (acetabulum). During total hip replacement surgery, worn and damaged portions of bone and cartilage are removed and replaced with an artificial hip joint. Specifically, a shell or cup replaces the socket, a stem is inserted into the thigh bone and a femoral head or ball at the top of the stem is fitted inside the curved artificial socket where the ball can slide around, allowing for movement.”

Previous total hip replacement systems approved for use by the FDA have utilized various combinations of metal, ceramic and polyethylene (a type of plastic), the FDA explains further. The Pinnacle CoMplete Acetabular Hip System is the first to combine a ceramic ball with a metal socket.

“Orthopedic surgeons and their patients now have an additional option for total hip replacement with the approval of the Pinnacle CoMplete Acetabular Hip System,” said Christy Foreman, director of the Office of Device Evaluation in the FDA’s Center for Devices and Radiological Health. The FDA’s approval is based on a two-year, randomized clinical trial which found no clinical difference between 194 patients implanted with the new ceramic-on-metal system and 196 patients in a control group who were implanted with a metal-on-metal hip replacement device. Two patients who received the Pinnacle CoMplete system had to undergo a revision surgery to replace their new implant, as opposed to three patients who required an additional surgery in the control group.

One of the conditions of the FDA approval will require DePuy Orthopaedics to conduct a postmarket study in order to monitor patients implanted with the Pinnacle CoMplete system to determine whether they experience any side effects, particularly raised metal ion concentration in their blood.

DePuy’s metal-on-metal Pinnacle system, similar to the company’s recalled ASR hip systems, has been causing difficulty for recipients because its components loosen, causing patients to experience swelling in the hip and groin area, along with excruciating pain in the hip and groin area, which can prevent patients from placing weight on the artificial hip, not to mention performing simple tasks such as walking, standing and sitting, according to reports received by the FDA. In addition, when the metal-on-metal implants begin to deteriorate, they deposit microscopic flakes of toxic metal into the surrounding tissue and bloodstream, which can lead to the growth of lesions and pseudotumors, as reported in the New York Times in March, 2010.

 

Filed Under: Depuy Hip Lawsuit, Featured Tagged With: , , , ,

Michigan Woman Files Complaint against Depuy’s ASR XL

May 5, 2011 by

(May 5, 2011)

Michigan Woman Files Complaint against Depuy’s ASR XL

(Courtesy Photo)

Another depuy asr lawsuit was filed by a Michigan woman against DePuy Orthopedics Inc. and its parent company, Johnson & Johnson Services Inc. citing that not only did they misrepresent the quality of their asr hip replacement
device to consumers, but they purposely concealed from the public its harmful effects. According to the records filed in the U.S. District Court for the Eastern District of Michigan, one of the main defects of the product is the recipient’s loss of mobility and range of motion.
The plaintiff further alleges that the Food and Drug Administration had received false statements from the defendants claiming that the depuy asr xl  device was “substantially equivalent” to the products that had been previously approved and that the testing of the products had been adequate. The device which had originally approved by the FDA in 2005, was later recalled in August. In a large number of patient cases, a second hip replacement surgery was needed due to the severe pain and swelling that was being experienced.

 

Due to the total hip replacement complications  that the plaintiff was having with the DePuy’s ASR XL Acetabular System, she decided to file on behalf of herself along with others who had been experiencing similar problems with the product. According to the suit, the hip replacement prosthesis was known for “becoming unstable and fail within months after surgical implantation despite the fact that such hip implant devices are supposed to last more than 15 years.” In addition to the unreliability of the product, the metal ball and socket bearing begins to produce metal-like debris over time and that could possibly eventually seep into patient’s surrounding bone and tissue. The plaintiff further charged that “As a result of these defects, patients that have had the device implanted have endured, or will endure, unnecessary severe pain and suffering; debilitation; a partial or complete lack of mobility; inflammation causing damage or death to surrounding tissue and bone; and a subsequent more difficult revision surgery to replace the faulty device giving rise to even more debilitation, a prolonged recovery time, and an increased risk of complications and death from surgery”.

If you or a loved one suffers from a Depuy defective hip replacement  device and feels that the manufactures should be held accountable, do not hesitate to contact a depuy lawyer  who can determine if you have a legitimate case.

Filed Under: Depuy Hip Lawsuit, Featured Tagged With: , , , , , ,

Depuy’s ASR XL Hip Implant is Accused of Being Defective

May 5, 2011 by
Depuy’s ASR XL Hip Implant is Accused of Being Defective

(Courtesy Photo)

(May 5, 2011)

DePuy Orthopedics Inc. and Johnson & Johnson Services Inc. was accused in a lawsuit by an Ohio woman of not having adequately tested their ASR XL Acetabular Hip Replacement System and not disclosing to the public the possible risks and side effects that could occur with the depuy asr hip implant.
.Allegations were also made against the defendants that the Food and Drug Administration were given reports that gave false information in regards to the products quality and adequate testing results.
The Ohio woman who filed the complaint in the U.S. District Court for the Northern District of Ohio stated that shortly after receiving the depuy asr xl in a hip replacement surgery, she began to experience severe pain and discomfort in her legs, groin area, lower back and then in her right hip. Even though she underwent a second surgery to replace the defective hip replacement , she continues to deal not only with the pain, but now also suffers from weakness in her hip area as well as a decreased range of motion. There is also a concern in regards to a “clicking and popping noise” that she fears that it may indicate that the implant is loose. The ASR hip, which was approved in 2005 by the FDA, was recalled in August 2010 after a large number of patients reported pain and swelling so severe that a second hip replacement surgery became necessary.
Other complaints filed about the ASR hip is that total hip replacement complications  begin to develop soon after the surgery despite the fact that the asr hip replacement  is supposed to last more than 15 years. Instead, hip replacement surgery complications  such as instability and overall failure seem to be occurring more frequently. Other concerns that have arisen are the implant’s metal ball and socket bearings that make up the hip joint. According to some studies, the metal ball and socket bearings can “generate medal debris” that after years of use can cause the particles to spread in and around the patient’s bone and tissue.

The plaintiff also alleges that the defendants were aware that patients the patients that had depuy hip replacement surgery
had little or almost no range of motions which would interfere with the patient’s being able to maintain a healthy and active lifestyle.
Has your quality of living been impaired to due to hip replacement surgery complications brought about by a defective hip replacement by the Depuy ASR XL? If so, contact a depuy lawyer who can assist you in finding out if you have a claim.

Filed Under: Depuy Hip Lawsuit, Featured Tagged With: , , , , , , , ,

Another Faulty Hip Replacement Device Finds Depuy in Court Again

May 5, 2011 by

Another Faulty Hip Replacement Device Finds Depuy in Court Again
(April 27, 2011) Once again, Depuy Orthopedics Inc. and Johnson & Johnson Services Inc. found themselves in court facing charges in reference to their defective hip replacement
product, the depuy asr xl . However, this time the depuy asr lawsuit was filed by a Houston, Texas woman claiming that the complications brought about by her original hip replacement required her to have a second surgery performed. According to the plaintiff, the pain and swelling she endured was so severe, she felt that she had no other alternative.
The complaint that had been filed in the U.S. District Court for the Southern District of Texas that had been filed on behalf of the plaintiff and others, accused the defendants of not being up front with the public about its products defects (such as the limited range of motion and loss of mobility) and that it purposely concealed the devices harmful effects. The Houston woman further alleged that falsified reports had been given to the Food and Drug Administration assuring them that Depuy ASR XL system had been tested and that there would be no total hip replacement complications as what was the case with the previous issue that led to the depuy asr hip recall .
The DePuy’s ASR XL Acetabular System had originally been approved in 2005 by the FDA but later had to be recalled in August due to the large amount of complaints by consumers who had used the device only to find that the product led to a defective hip replacement
Many of the complaints dealt with reports of severe pain and swelling as indicted by the plaintiff. According to the suit, the hip replacement prosthesis has been known to “become unstable and fail within months after surgical implantation despite the fact that such hip implant devices are supposed to last more than 15 years.” In addition, the implant’s metal ball and socket bearings that make up the hip joint “generate medal debris over time from wear and tear that can spread throughout the patient’s surrounding bone and tissue”.
The plaintiff’s lawyers concluded that “Had the plaintiff known that the ASR Hip Implant Device caused pain, swelling, inflammation, infection, and damage to surrounding bone tissue, she would have elected to not have had depuy hip replacement surgery
In the event that you have had hip replacement surgery with a Depuy ASR hip replacement and have one of the many who have suffered complications, you are encouraged to contact a depuy attorney to see if you have a case that could led to a depuy hip lawsuit .

Filed Under: Breaking News, Depuy Hip Lawsuit, Featured Tagged With: , , , , , , ,

Problems with DePuy Hip Replacement Devices Date Back to 2007

March 15, 2011 by

(March 15, 2011)

Problems with DePuy Hip Replacement Devices Date Back to 2007

(Courtesy Photo)

While it is impossible to pinpoint exactly when executives at DePuy became aware of problems associated with its hip replacement devices, evidence from artificial joint registries outside of the United States began documenting issues with the devices back in 2007. DePuy did not choose to recall its depuy asr xl Acetabular System and ASR Hip Resurfacing System until August, 2010.
Australia, the United Kingdom, Norway and Sweden all have artificial joint registries in place to carefully track data on procedures such as depuy hip replacement surgery . In 2007, the Australian National Joint Replacement Registry began to notice problems with the depuy hip replacement devices. By 2008, it determined that the DePuy devices were four to five times more likely to fail within three years than any other hip replacement device on the market. Pressure from the Australian registry prompted DePuy to pull its products from the Australian market in 2009. Joint registries in England and Wales began compiling similar data, illustrating a five-year failure rate of approximately 12.5 percent, which is double the industry average.
The United States does not have any such joint registry in place. It wasn’t until two years after the U.S. Food and Drug Administration (FDA) began receiving complaints about its hip replacement devices that led to a depuy hip replacement recall . With a depuy hip replacement surgery performed in the U.S. at least 250,000 each year, it is impossible to know exactly how many people have been affected by these defective devices. Approximately 93,000 DePuy devices have been implanted worldwide, but without documentation it will be difficult to calculate the damage based only on the hundreds of complaints received by the FDA. There is no way to know how many unreported cases of failure have been brought to light, or how many patients are suffering in silence thinking that their symptoms are typical of the depuy hip replacement procedure.
American Law Patners has experienced hip replacement lawyers working diligently to advocate on behalf of victims of the depuy hip recall . Patients experiencing symptoms such as pain, swelling and decreased mobility as a result of a depuy hip replacement surgery should contact their physicians for an evaluation. Once a diagnosis is obtained, American Law partners recommends visiting this web site often to stay informed of the latest developments in the ongoing litigation against DePuy Orthopaedics.

Filed Under: Depuy Hip Lawsuit, Featured Tagged With: , , , , ,

Departure of DePuy President, Postponement of MDL Status Conference

March 14, 2011 by

(March 14, 2011)

DePuy spokesperson Mindy Tinsley announced that David Floyd, president of DePuy since 2007, has resigned his position “to pursue outside interests.” Floyd will leave after a short transition period. No replacement for Floyd has yet been named. DePuy, a Johnson & Johnson company, had a depuy asr recall on devices globally after the National Joint Registry of England and Wales made public data showing that, within five years, about 12% of recipients of the hip resurfacing system and about 13% of recipients of the acetabular system needed corrective surgery.

A hundred or so, depuy class action lawsuits, stemming from the Depuy hip recall, have to date, been filed in the United States, and in early December of last year, the United States Judicial Panel on Multidistrict Litigation approved the depuy asr xl litigation for consolidated pretrial proceedings and assigned the case—In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products (no. 1:10 md 2197)—to Judge David A. Katz of the United States District Court for the Northern District of Ohio.
By order dated March 4, 2011, Judge Katz postponed from March 9 to April 5 a status conference at which counsel for the respective parties will present to the court a comprehensive plan to proceed with pretrial discovery. The status conference will be held at the United States Courthouse in West Palm Beach, Florida.

Filed Under: Depuy Hip Lawsuit, Featured Tagged With: , , ,